|
WO2014183168A1
|
|
Inhibitory propeptides
|
|
AU2013203251A1
|
|
Biofilm treatment
|
|
AU2013203250A1
|
|
Immunology treatment for biofilms
|
|
AU2013203249A1
|
|
Prevention, treatment and diagnosis of P.gingivalis infection
|
|
WO2013063656A1
|
|
Gingipain inhibitory propeptides
|
|
MY162557A
|
|
Treatment or prevention of infection
|
|
AU2010317661A1
|
|
Antibiofilm glycopeptides
|
|
EP2443143A1
|
|
Casein derived protease inhibitory peptides
|
|
WO2010132954A1
|
|
Method of treating periodontal disease by administering antagonists of par-2
|
|
WO2010031127A1
|
|
Detection of treponema infection
|
|
MX367677B
|
|
Prevention, treatment and diagnosis of p.gingivalis infection.
|
|
EP2328914A1
|
|
Prevention, treatment and diagnosis of p.gingivalis infection
|
|
NZ582438A
|
|
A composition for use in raising an immune response to p. gingivalis
|
|
WO2009006699A1
|
|
Biofilm treatment
|
|
WO2008086566A1
|
|
Bioactive delivery device
|
|
EP2038297A1
|
|
Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
|
